CSL buys goods and services from other companies to operate a global business researching and manufacturing medicines and vaccines. Most of CSL’s emissions (85%) come from 42,000 different suppliers, who supply everything from medicine vials and boxes to transportation and professional services.
In 2022, when CSL first shared its carbon emissions targets, the company set a target to have suppliers who produce 67% of its Scope 3 emissions establish their own reduction targets aligned with the Science-Based Targets initiative by 2030. Now, after three of four waves of supplier engagement, CSL calculates that it has reached 50% of the targeted 67%.